A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)
Clinical trial NCT01219933 · COMPLETED
Trial details
- NCT number
- NCT01219933
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-03-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.